mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |